Teachers Retirement System of The State of Kentucky Sells 302 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

Teachers Retirement System of The State of Kentucky decreased its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 4.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,358 shares of the medical instruments supplier’s stock after selling 302 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in West Pharmaceutical Services were worth $2,239,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. CI Investments Inc. grew its holdings in shares of West Pharmaceutical Services by 33.0% during the third quarter. CI Investments Inc. now owns 2,493 shares of the medical instruments supplier’s stock worth $935,000 after purchasing an additional 618 shares during the last quarter. Acadian Asset Management LLC raised its stake in shares of West Pharmaceutical Services by 89.7% during the third quarter. Acadian Asset Management LLC now owns 14,243 shares of the medical instruments supplier’s stock valued at $5,340,000 after acquiring an additional 6,736 shares during the last quarter. Mariner LLC lifted its holdings in shares of West Pharmaceutical Services by 3.3% during the third quarter. Mariner LLC now owns 12,077 shares of the medical instruments supplier’s stock worth $4,531,000 after purchasing an additional 388 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of West Pharmaceutical Services by 89.0% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 18,822 shares of the medical instruments supplier’s stock worth $7,062,000 after purchasing an additional 8,861 shares during the last quarter. Finally, Stifel Financial Corp increased its holdings in West Pharmaceutical Services by 1.8% in the third quarter. Stifel Financial Corp now owns 46,968 shares of the medical instruments supplier’s stock valued at $17,624,000 after purchasing an additional 809 shares during the period. Institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Stock Up 2.0 %

Shares of WST opened at $328.47 on Friday. The company has a market capitalization of $23.93 billion, a PE ratio of 43.33, a PEG ratio of 5.69 and a beta of 1.01. The stock’s 50-day moving average price is $348.71 and its two-hundred day moving average price is $361.15. The company has a current ratio of 2.61, a quick ratio of 1.95 and a debt-to-equity ratio of 0.03. West Pharmaceutical Services, Inc. has a 12 month low of $310.00 and a 12 month high of $415.73.

West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, April 25th. The medical instruments supplier reported $1.56 EPS for the quarter, beating the consensus estimate of $1.29 by $0.27. West Pharmaceutical Services had a return on equity of 20.57% and a net margin of 19.42%. The business had revenue of $695.40 million for the quarter, compared to analysts’ expectations of $670.62 million. During the same period in the prior year, the business posted $1.98 earnings per share. The firm’s revenue was down 3.0% on a year-over-year basis. On average, analysts anticipate that West Pharmaceutical Services, Inc. will post 7.76 EPS for the current year.

West Pharmaceutical Services Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 7th. Stockholders of record on Wednesday, July 31st will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.24%. The ex-dividend date is Wednesday, July 31st. West Pharmaceutical Services’s dividend payout ratio is 10.55%.

Insider Activity at West Pharmaceutical Services

In other West Pharmaceutical Services news, CEO Eric Mark Green sold 66,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $366.65, for a total value of $24,198,900.00. Following the transaction, the chief executive officer now directly owns 152,908 shares of the company’s stock, valued at $56,063,718.20. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other West Pharmaceutical Services news, SVP Silji Abraham sold 1,800 shares of West Pharmaceutical Services stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $330.78, for a total value of $595,404.00. Following the completion of the sale, the senior vice president now directly owns 2,860 shares of the company’s stock, valued at $946,030.80. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Eric Mark Green sold 66,000 shares of the company’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $366.65, for a total transaction of $24,198,900.00. Following the transaction, the chief executive officer now owns 152,908 shares in the company, valued at approximately $56,063,718.20. The disclosure for this sale can be found here. 0.53% of the stock is owned by corporate insiders.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.